The gap between the evidence for contingency management (CM) and patients’ ability to access it is so dire that, in Fall of 2021, the New York Times ran an article titled, ‘This addiction treatment works. Why is it so underused?’ The article elucidated the myriad of barriers that limit widespread access to CM in the United States including (but not limited to) insufficient funding, restrictive federal policies and provider attitudes/stigma. Readers of the article were left asking one of the most pressing public health questions of our time: ‘How do we close the gap?’